Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
CSL ( (AU:CSL) ) has shared an announcement.
CSL Limited announced the cessation of 6,106 conditional rights to securities as the conditions for these rights were not met or became incapable of being satisfied. This announcement may impact CSL’s capital structure and could have implications for stakeholders regarding the company’s financial strategies and market operations.
More about CSL
CSL Limited operates in the biotechnology industry, focusing on the development and manufacturing of innovative medicines and vaccines. The company is known for its contributions to global health through its range of biopharmaceutical products.
YTD Price Performance: -11.77%
Average Trading Volume: 992
Technical Sentiment Signal: Strong Buy
Current Market Cap: $70.21B
See more data about CSL stock on TipRanks’ Stock Analysis page.